Telomir Pharmaceuticals Inc (TELO)

Currency in USD
1.11
-0.01(-0.89%)
Real-time Data·
TELO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.111.12
52 wk Range
0.892.09
Key Statistics
Prev. Close
1.12
Open
1.12
Day's Range
1.11-1.12
52 wk Range
0.89-2.09
Volume
5.91K
Average Volume (3m)
95.62K
1-Year Change
-5.9322%
Book Value / Share
0.07
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TELO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Rodman & Renshaw
Buy8.00+614.29%-New CoverageJan 13, 2026

Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
-0.79 / -0.04
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TELO Income Statement

Compare TELO to Peers and Sector

Metrics to compare
TELO
Peers
Sector
Relationship
P/E Ratio
−1.5x−17.1x−0.4x
PEG Ratio
0.01−0.080.00
Price/Book
15.3x5.0x2.6x
Price / LTM Sales
-14.3x3.1x
Upside (Analyst Target)
-89.0%49.0%
Fair Value Upside
Unlock−0.6%7.1%Unlock

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson’s disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer’s disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.09M3.03%2.34M
Other Institutional Investors
11.15M16.21%12.49M
Public Companies & Retail Investors
55.54M80.76%62.20M
Total
68.77M100.00%77.03M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bayshore Trust9.79%6,732,0777,540
MIRA Pharmaceuticals, Inc.5.12%3,521,1273,944

People Also Watch

9.8300
DFNS
+6.16%
0.828
IVVD
+2.92%
7.24
SION
-1.03%
58.35
IONS
-4.86%

FAQ

What Is the Telomir Pharmaceuticals (TELO) Stock Price Today?

The Telomir Pharmaceuticals stock price today is 1.11 USD.

What Stock Exchange Does Telomir Pharmaceuticals Trade On?

Telomir Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Telomir Pharmaceuticals?

The stock symbol for Telomir Pharmaceuticals is "TELO."

What Is the Telomir Pharmaceuticals Market Cap?

As of today, Telomir Pharmaceuticals market cap is 77.03M USD.

What Is Telomir Pharmaceuticals's Earnings Per Share (TTM)?

The Telomir Pharmaceuticals EPS (TTM) is -1.29.

When Is the Next Telomir Pharmaceuticals Earnings Date?

Telomir Pharmaceuticals will release its next earnings report on Dec 02, 2026.

From a Technical Analysis Perspective, Is TELO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Telomir Pharmaceuticals Stock Split?

Telomir Pharmaceuticals has split 0 times.

What is the current trading status of Telomir Pharmaceuticals (TELO)?

As of Sep 03, 2026, Telomir Pharmaceuticals (TELO) is trading at a price of 1.11 USD, with a previous close of 1.12 USD. The stock has fluctuated within a day range of 1.11 USD to 1.12 USD, while its 52-week range spans from 0.89 USD to 2.09 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.